SEC Form D private-offering filing

BlossomHill Therapeutics, Inc.

A new SEC Form D private-offering notice from San Diego, CA, a $84,152,909 filer-stated offering target in Biotech. The source filing is one click away.

BlossomHill Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing small molecule cancer therapies, including a macrocyclic OMNI-EGFR inhibitor for non small cell lung cancer.

Filed 2025-12-10Filed to raise $84,152,909First money in 2025-11-25Raised so far $84,152,909HQ (as filed) San Diego, CASector Biotech Stage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified bhtherapeutics.com↗Named in the filing 7 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.